Rapid detection of polymyxin-resistant enterobacteriaceae from blood cultures

Journal of Clinical Microbiology

Volumn 54, Issue 9, 2016, Pages 2273-2277

  Jayol, Aurélie ^a,b   Dubois, Véronique ^b   Poirel, Laurent ^a   Nordmanna, Patrice ^a,c  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; POLYMYXIN; ANTIINFECTIVE AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;

ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD CULTURE; CITROBACTER KOSERI; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HAFNIA ALVEI; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROTEUS VULGARIS; PROVIDENCIA STUARTII; SERRATIA MARCESCENS; COLOR; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; EVALUATION STUDY; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PH; PROCEDURES; SENSITIVITY AND SPECIFICITY; TIME FACTOR;

ANTI-BACTERIAL AGENTS; BLOOD CULTURE; COLOR; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; HYDROGEN-ION CONCENTRATION; INDICATORS AND REAGENTS; MICROBIAL SENSITIVITY TESTS; POLYMYXINS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 84983666720     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00918-16     Document Type: Article

References (23)

1. Nordmann P, Poirel L. 2014. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect 20:821-830. http://dx.doi.org/10.1111/1469-0691.12719.
2. Livermore DM, Warner M, Mushtaq S, Doumith M, Zhang J, Woodford N. 2011. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents 37:415-419. http://dx.doi.org/10.1016/j.ijantimicag.2011.01.012.
3. Olaitan AO, Morand S, Rolain JM. 2014. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol 5:643. http://dx.doi.org/10.3389/fmicb.2014.00643.
4. Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, Yu LF, Gu D, Ren H, Chen X, Lv L, He D, Zhou H, Liang Z, Liu JH, Shen J. 2016. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 16:161-168. http://dx.doi.org/10.1016/S1473-3099(15)00424-7.
5. Humphries RM. 2015. Susceptibility testing of the polymyxins: where are we now? Pharmacotherapy 35:22-27. http://dx.doi.org/10.1002/phar .1505.
6. Lo-Ten-Foe JR, de Smet AM, Diederen BM, Kluytmans JA, van Keulen PH. 2007. Comparative evaluation of the Vitek 2, disk diffusion, Etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob Agents Chemother 51: 3726-3730. http://dx.doi.org/10.1128/AAC.01406-06.
7. Maalej SM, Meziou MR, Rhimi FM, Hammami A. 2011. Comparison of disc diffusion, Etest and agar dilution for susceptibility testing of colistin against Enterobacteriaceae. Lett Appl Microbiol 53:546-551. http://dx.doi .org/10.1111/j.1472-765X.2011.03145.x.
8. Tan TY, Ng SY. 2007. Comparison of Etest, Vitek and agar dilution for susceptibility testing of colistin. Clin Microbiol Infect 13:541-544. http: //dx.doi.org/10.1111/j.1469-0691.2007.01708.x.
9. Perez LR. 2015. Evaluation of polymyxin susceptibility profile among KPC-producing Klebsiella pneumoniae using Etest and MicroScan Walk-Away automated system. APMIS 123:951-954. http://dx.doi.org/10.1111 /apm.12438.
10. Kumar A, Ellis P, Arabi Y, Roberts D, Light B, Parrillo JE, Dodek P, Wood G, Kumar A, Simon D, Peters C, Ahsan M, Chateau D, Cooperative Antimicrobial Therapy of Septic Shock Database Research Group. 2009. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136:1237-1248. http://dx.doi.org/10.1378/chest.09-0087.
11. Garnacho-Montero J, Ortiz-Leyba C, Herrera-Melero I, Aldabó-Pallás T, Cayuela-Dominguez A, Marquez-Vacaro JA, Carbajal-Guerrero J, Garcia-Garmendia JL. 2008. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study. J Antimicrob Chemother 61:436-441. http://dx.doi.org/10.1093/jac/dkm460.
12. Giani T, Arena F, Vaggelli G, Conte V, Chiarelli A, Henrici De Angelis L, Fornaini R, Grazzini M, Niccolini F, Pecile P, Rossolini GM. 2015. Large nosocomial outbreak of colistin-resistant, carbapenemaseproducing Klebsiella pneumoniae traced to clonal expansion of an mgrB deletion mutant. J Clin Microbiol 53:3341-2234. http://dx.doi.org/10 .1128/JCM.01017-15.
13. Nordmann P, Jayol A, Poirel L. 2016. Rapid detection of polymyxin resistance in Enterobacteriaceae. Emerg Infect Dis 22:1038-1043. http://dx .doi.org/10.3201/eid2206.151840.
14. Jayol A, Nordmann P, Brink A, Poirel L. 2015. Heteroresistance to colistin in Klebsiella pneumoniae associated with alterations in the PhoPQ regulatory system. Antimicrob Agents Chemother 59:2780-2784. http: //dx.doi.org/10.1128/AAC.05055-14.
15. Jayol A, Nordmann P, Desroches M, Decousser JW, Poirel L. 2016. Acquisition of broad-spectrum cephalosporin resistance leading to colistin resistance in Klebsiella pneumoniae. Antimicrob Agents Chemother 60:3199-3201. http://dx.doi.org/10.1128/AAC.00237-16.
16. Jayol A, Poirel L, Brink A, Villegas MV, Yilmaz M, Nordmann P. 2014. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin. Antimicrob Agents Chemother 58:4762-4766. http://dx.doi.org/10.1128/AAC .00084-14.
17. Jayol A, Poirel L, Villegas MV, Nordmann P. 2015. Modulation of mgrB gene expression as a source of colistin resistance in Klebsiella oxytoca. Int J Antimicrob Agents 46:108-110. http://dx.doi.org/10.1016/j.ijantimicag .2015.02.015.
18. Poirel L, Jayol A, Bontron S, Villegas MV, Ozdamar M, Türkoglu S, Nordmann P. 2015. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother 70:75-80. http://dx.doi.org/10.1093/jac/dku323.
19. Poirel L, Kieffer N, Liassine N, Thanh D, Nordmann P. 2016. Plasmidmediated carbapenem and colistin resistance in a clinical isolate of Escherichia coli. Lancet Infect Dis 16:281-282. http://dx.doi.org/10.1016/S1473-3099(16)00007-4.
20. Dortet L, Bréchard L, Poirel L, Nordmann P. 2014. Rapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures. Clin Microbiol Infect 20:340-344. http://dx.doi.org/10.1111/1469-0691.12318.
21. Clinical and Laboratory Standards Institute. 2012. Methods for dilution of antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-9th ed. CLSI document M07-A9. Clinical and Laboratory Standards Institute, Wayne, P.A.
22. Clinical and Laboratory Standards Institute. 2015. Performance standards for antimicrobial susceptibility testing. CLSI document M100-S25. Clinical and Laboratory Standards Institute, Wayne, P.A.
23. European Committee on Antimicrobial Susceptibility Testing. 2014. Breakpoint tables for interpretation of MICs and zone diameters, version 2.0. European Committee on Antimicrobial Susceptibility Testing, Basel, Switzerland.